Zurück zu Projekte

25771.1 PFLS-LS

Immobilized sortase enzymes for the Production of Antibody-drug conjugates IMPACT

Zusammenfassung

Immobilized sortase enzymes for the Production of Antibody-drug conjugates IMPACT

Weitere Texte

Abstract

The application of enzymes in continuous production processes is often hindered by the fragility of these natural biocatalysts under operational conditions. In IMPACT, the project partners shall strive to develop a novel nanobiocatalytic material allowing for a drastically enhanced stability of enzymes. The protection strategy relies on the growth, at the surface of immobilized enzymes, of a protective biomimetic layer partially shielding the enzyme. While this layer will provide the enzyme with enhanced resistance to operational stress conditions, its partial nature (i.e. covering only partially the enzyme) will allow the use of this nanomaterial for applications where large substrates are targeted. This is the case in IMPACT as the targeted application is the production of antibody-drug conjugates for use in cancer therapy (multiple myeloma). The project partners shall focus on the development of the nanobiocatalytic material and demonstrate the superiority of the nanobiocatalysts produced as compared to the soluble or immobilized counterparts. In a further phase, the technology developed in IMPACT will be implemented in a flow-through reactor enabling the continuous production of ADCs. Besides the targeted application, IMPACT is expected to open a wealth of new opportunities for the implementation partners for empowering enzymes in different industrial applications.

Beteiligte

Yves Dudal

Wirtschaftspartner

yves.dudal@inofea.com

INOFEA AG Yves Dudal Hochbergerstr. 60c 4057 Basel BS CH

Patrick Shahgaldian

Kontaktperson

patrick.shahgaldian@fhnw.ch

FHNW Fachhochschule Nordwestschweiz Patrick Shahgaldian Hofackerstrasse 30 4132 Muttenz BL CH

Projektdetails

Forschungsstelle
INNOSUISSE
Projektstatus
Abgeschlossen
Projekttyp
Forschungsprojekt
Startdatum
2017-04-30
Enddatum
2019-01-31
Bewilligte Gesamtkosten
CHF 250110.00
Sektion
20 Förderbereich Life Sciences
NABS Politikbereich
Industrielle Produktivität und Technologie

Forschungsdisziplinen

  • T490 Biotechnology 100.0%